EC
ABBV icon

Eaton-Cambridge’s AbbVie ABBV Stock Holding History

Eaton-Cambridge’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Buy
1,050
+35
+3% +$7.53K 0.07% 57
2026
Q1 		$221K Buy
1,015
+110
+12% +$24.4K 0.07% 53
2025
Q4 		$207K Buy
+905
New +$206K 0.07% 44

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Eaton-Cambridge's ABBV Position: Q2 2026 in Review

Eaton-Cambridge increased its AbbVie (ABBV) stake by 3.4% in Q2 2026, buying an estimated $7.53K and bringing the position to 1,050 shares worth $264K. The position accounts for 0.07% of the portfolio, ranked #57.

Eaton-Cambridge first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Eaton-Cambridge held 1,050 shares of AbbVie worth $264K as of Q2 2026.
  • Eaton-Cambridge bought 35 AbbVie shares in Q2 2026, an estimated $7.53K.
  • AbbVie made up 0.07% of Eaton-Cambridge's portfolio in Q2 2026, its #57 holding.
  • Eaton-Cambridge first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Eaton-Cambridge's 13F filing for Q2 2026, filed 23 Jul 2026.